(redirected from hypereosinophilic syndrome)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to hypereosinophilic syndrome: eosinophilia
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for syndrome

Words related to syndrome

References in periodicals archive ?
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
The report reviews pipeline therapeutics for Hypereosinophilic Syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources
Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome.
12] concentrations frequently occur with myeloproliferative disorders, hypereosinophilic syndromes, and hepatic diseases (3-11).
Coverage includes techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP 1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of acute myeloid leukemia by DNA- oligonucleotide microarrays, detection of the V617F JAK2 mutation in myeloproliferative disorders, gene rearrangements, FLT3 mutations andWT-1 overexpression.
It also reviews key players involved in the therapeutic development for Hypereosinophilic Syndrome.
The purpose of this review is to provide an overview of the differential diagnosis for eosinophilia, to recommend specific steps for the pathologist evaluating blood and bone marrow samples, and to emphasize 2 important causes of eosinophilia that require specific ancillary tests for diagnosis: myeloproliferative neoplasm with PDGFRA rearrangement and lymphocyte-variant hypereosinophilic syndrome.
In addition, the imatinib mesylate tablets have been approved for adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL), adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans, as well as for adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive gastrointestinal stromal tumors (GIST) .
GlobalData's clinical trial report, "Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Hypereosinophilic Syndrome clinical trials scenario.
1) It can be either primary (idiopathic) or secondary as a result of systemic conditions such as hypereosinophilic syndrome, celiac disease, Crohn disease, Churg-Strauss syndrome, and helminthic infection or of drugs such as enalapril, gemfibrozil, cyclosporine, naproxen, clozapine, rifampicin and gold.
17) Eosinophilia may be observed in: (1) benign reactive eosinophilia, (2) eosinophilia of miscellaneous malignant disorders, and (3) sustained idiopathic eosinophilia, including idiopathic hypereosinophilic syndrome and eosinophilic leukemia.
Global Markets Direct's, 'Hypereosinophilic Syndrome - Pipeline Review, H1 2012', provides an overview of the Hypereosinophilic Syndrome therapeutic pipeline.